Bio-Rad Laboratories (BIO) Operating Income Growth (5y) (2014 - 2026)
Bio-Rad Laboratories (BIO) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Bio-Rad Laboratories | 8.54 Bn | 6.98 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.50% |
| Dec 31, 2025 | -21.43% |
| Sep 30, 2025 | -9.84% |
| Jun 30, 2025 | 8.30% |
| Mar 31, 2025 | -20.45% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | 2.34% |
| Jun 30, 2024 | 12.47% |
| Mar 31, 2024 | -4.66% |
| Dec 31, 2023 | 19.33% |
| Sep 30, 2023 | 20.18% |
| Jun 30, 2023 | 15.40% |
| Mar 31, 2023 | 7.24% |
| Dec 31, 2022 | 20.92% |
| Sep 30, 2022 | 19.55% |
| Jun 30, 2022 | 136.67% |
| Mar 31, 2022 | 41.07% |
| Dec 31, 2021 | 43.95% |
| Sep 30, 2021 | 47.19% |
| Jun 30, 2021 | 35.92% |